Annual EBIT
-$19.10 M
+$15.47 M+44.75%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual earnings before interest & taxes is -$19.10 million, with the most recent change of +$15.47 million (+44.75%) on December 31, 2023.
- During the last 3 years, KRBP annual EBIT has risen by +$99.80 thousand (+0.52%).
- KRBP annual EBIT is now -500.05% below its all-time high of -$3.18 million, reached on December 31, 2018.
Performance
KRBP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.50 M
-$632.00 K-10.77%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly earnings before interest & taxes is -$6.50 million, with the most recent change of -$632.00 thousand (-10.77%) on September 30, 2024.
- Over the past year, KRBP quarterly EBIT has dropped by -$632.00 thousand (-10.77%).
- KRBP quarterly EBIT is now -2316.36% below its all-time high of -$269.00 thousand, reached on June 30, 2019.
Performance
KRBP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$21.50 M
-$2.75 M-14.64%
September 30, 2024
Summary
- As of February 7, 2025, KRBP TTM earnings before interest & taxes is -$21.50 million, with the most recent change of -$2.75 million (-14.64%) on September 30, 2024.
- Over the past year, KRBP TTM EBIT has dropped by -$2.75 million (-14.64%).
- KRBP TTM EBIT is now -5452.05% below its all-time high of -$387.30 thousand, reached on March 31, 2019.
Performance
KRBP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KRBP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.8% | -10.8% | -14.6% |
| 3 y3 years | +0.5% | -1.1% | +28.4% |
| 5 y5 years | -500.1% | -1.1% | +28.4% |
KRBP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.8% | -73.2% | +45.2% | -14.6% | +43.8% |
| 5 y | 5-year | -415.4% | +44.8% | -250.8% | +45.2% | -480.3% | +43.8% |
| alltime | all time | -500.1% | +44.8% | -2316.4% | +45.2% | -5452.1% | +43.8% |
Kiromic BioPharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.50 M(+10.8%) | -$21.50 M(+14.6%) |
| Jun 2024 | - | -$5.87 M(+15.6%) | -$18.76 M(-2.9%) |
| Mar 2024 | - | -$5.08 M(+25.1%) | -$19.32 M(+1.2%) |
| Dec 2023 | -$19.10 M(-44.7%) | -$4.06 M(+8.1%) | -$19.10 M(-13.0%) |
| Sep 2023 | - | -$3.75 M(-41.6%) | -$21.95 M(-27.0%) |
| Jun 2023 | - | -$6.43 M(+32.4%) | -$30.05 M(-6.2%) |
| Mar 2023 | - | -$4.86 M(-29.7%) | -$32.06 M(-7.3%) |
| Dec 2022 | -$34.56 M(+35.1%) | -$6.91 M(-41.7%) | -$34.56 M(-9.7%) |
| Sep 2022 | - | -$11.86 M(+40.6%) | -$38.29 M(+17.6%) |
| Jun 2022 | - | -$8.43 M(+14.5%) | -$32.55 M(+11.9%) |
| Mar 2022 | - | -$7.37 M(-30.7%) | -$29.09 M(+13.7%) |
| Dec 2021 | -$25.58 M | -$10.63 M(+73.6%) | -$25.58 M(+38.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$6.12 M(+23.2%) | -$18.51 M(+25.1%) |
| Jun 2021 | - | -$4.97 M(+29.1%) | -$14.80 M(-30.2%) |
| Mar 2021 | - | -$3.85 M(+8.1%) | -$21.20 M(+10.4%) |
| Dec 2020 | -$19.20 M(+418.1%) | -$3.56 M(+47.4%) | -$19.20 M(+7.8%) |
| Sep 2020 | - | -$2.42 M(-78.7%) | -$17.80 M(+9.4%) |
| Jun 2020 | - | -$11.37 M(+513.5%) | -$16.27 M(+214.6%) |
| Mar 2020 | - | -$1.85 M(-14.6%) | -$5.17 M(+39.5%) |
| Dec 2019 | -$3.71 M(+16.4%) | -$2.17 M(+146.7%) | -$3.71 M(+141.3%) |
| Sep 2019 | - | -$879.50 K(+227.0%) | -$1.54 M(+134.0%) |
| Jun 2019 | - | -$269.00 K(-30.5%) | -$656.30 K(+69.5%) |
| Mar 2019 | - | -$387.30 K | -$387.30 K |
| Dec 2018 | -$3.18 M | - | - |
FAQ
- What is Kiromic BioPharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kiromic BioPharma?
- What is Kiromic BioPharma annual EBIT year-on-year change?
- What is Kiromic BioPharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly EBIT year-on-year change?
- What is Kiromic BioPharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kiromic BioPharma?
- What is Kiromic BioPharma TTM EBIT year-on-year change?
What is Kiromic BioPharma annual earnings before interest & taxes?
The current annual EBIT of KRBP is -$19.10 M
What is the all time high annual EBIT for Kiromic BioPharma?
Kiromic BioPharma all-time high annual earnings before interest & taxes is -$3.18 M
What is Kiromic BioPharma annual EBIT year-on-year change?
Over the past year, KRBP annual earnings before interest & taxes has changed by +$15.47 M (+44.75%)
What is Kiromic BioPharma quarterly earnings before interest & taxes?
The current quarterly EBIT of KRBP is -$6.50 M
What is the all time high quarterly EBIT for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly earnings before interest & taxes is -$269.00 K
What is Kiromic BioPharma quarterly EBIT year-on-year change?
Over the past year, KRBP quarterly earnings before interest & taxes has changed by -$632.00 K (-10.77%)
What is Kiromic BioPharma TTM earnings before interest & taxes?
The current TTM EBIT of KRBP is -$21.50 M
What is the all time high TTM EBIT for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM earnings before interest & taxes is -$387.30 K
What is Kiromic BioPharma TTM EBIT year-on-year change?
Over the past year, KRBP TTM earnings before interest & taxes has changed by -$2.75 M (-14.64%)